Frontiers in Cardiovascular Medicine (Sep 2022)

Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease

  • Thomas Stuckey,
  • Frederick Meine,
  • Thomas McMinn,
  • Jeremiah P. Depta,
  • Brett Bennett,
  • Thomas McGarry,
  • William Carroll,
  • David Suh,
  • John A. Steuter,
  • Michael Roberts,
  • Horace R. Gillins,
  • Emmanuel Lange,
  • Farhad Fathieh,
  • Timothy Burton,
  • Ali Khosousi,
  • Ian Shadforth,
  • William E. Sanders,
  • Mark G. Rabbat

DOI
https://doi.org/10.3389/fcvm.2022.956147
Journal volume & issue
Vol. 9

Abstract

Read online

IntroductionMultiple trials have demonstrated broad performance ranges for tests attempting to detect coronary artery disease. The most common test, SPECT, requires capital-intensive equipment, the use of radionuclides, induction of stress, and time off work and/or travel. Presented here are the development and clinical validation of an office-based machine learned algorithm to identify functionally significant coronary artery disease without radiation, expensive equipment or induced patient stress.Materials and methodsThe IDENTIFY trial (NCT03864081) is a prospective, multicenter, non-randomized, selectively blinded, repository study to collect acquired signals paired with subject meta-data, including outcomes, from subjects with symptoms of coronary artery disease. Time synchronized orthogonal voltage gradient and photoplethysmographic signals were collected for 230 seconds from recumbent subjects at rest within seven days of either left heart catheterization or coronary computed tomography angiography. Following machine learning on a proportion of these data (N = 2,522), a final algorithm was selected, along with a pre-specified cut point on the receiver operating characteristic curve for clinical validation. An unseen set of subject signals (N = 965) was used to validate the algorithm.ResultsAt the pre-specified cut point, the sensitivity for detecting functionally significant coronary artery disease was 0.73 (95% CI: 0.68–0.78), and the specificity was 0.68 (0.62–0.74). There exists a point on the receiver operating characteristic curve at which the negative predictive value is the same as coronary computed tomographic angiography, 0.99, assuming a disease incidence of 0.04, yielding sensitivity of 0.89 and specificity of 0.42. Selecting a point at which the positive predictive value is maximized, 0.12, yields sensitivity of 0.39 and specificity of 0.88.ConclusionThe performance of the machine learned algorithm presented here is comparable to common tertiary center testing for coronary artery disease. Employing multiple cut points on the receiver operating characteristic curve can yield the negative predictive value of coronary computed tomographic angiography and a positive predictive value approaching that of myocardial perfusion imaging. As such, a system employing this algorithm may address the need for a non-invasive, no radiation, no stress, front line test, and hence offer significant advantages to the patient, their physician, and healthcare system.

Keywords